Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-103323
Filing Date
2025-08-05
Accepted
2025-08-05 18:51:26
Documents
1
Period of Report
2025-08-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 8215
  Complete submission text file 0000950170-25-103323.txt   9610
Mailing Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address
BELANOFF JOSEPH K (Reporting) CIK: 0001286199 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50679 | Film No.: 251186645